The webinar will feature a presentation from Key Opinion Leader (KOL) Christophe Martinaud, MD, PhD who will discuss the current treatment landscape and unmet need in blood grouping and donor disease screening.

The Quotient team will present their MosaiQ solution, designed to provide multimodal, multiplexed testing on a fully automated platform, delivering clinical and economic value to customers, transforming patient care. MosaiQ enables increased workflow efficiency, more comprehensive blood donor screening, while addressing budget constraints. The team will highlight how MosaiQ is positioned to be the world’s first fully automated and consolidated testing platform.

A live question and answer session will follow.